ArticleScientific reports2025
A multimodal multipath AI system for assessing PAH after VSD correction on echocardiography and chest radiography images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Developing a novel artificial intelligence (AI) system that can automatically detect pulmonary arterial hypertension (PAH) after correcting the ventricular septal defect (VSD) and to help clinicians make reasonable treatment plans. We analyzed data from 1,316 patients under 1 year old who underwent VSD surgery at Women and Children's Hospital, Qingdao University and Qingdao Central Hospital from January 2017 to December 2023. Pediatric patients were classified into two groups based on postoperative echocardiography and cardiac catheterization results: a normal pulmonary artery pressure group (NG) and PAH after correcting VSD group (CD). We trained and validated a multimodal multipath AI system (MMAI) using echocardiography (Echo) and chest digital radiography (DR) dataset. Dice similarity coefficient (DSC) is used to measure the effectiveness of the model in automatic contour segmentation of images. We assessed the recognition performance of MMAI using the area under the receiver operating characteristic curve (AUC), accuracy, and F1-score through internal and external test sets. The ResNet-50 model demonstrates good performance in automatic cardiac contour segmentation, with DSC values of 0.950 ± 0.017 (Echo) and 0.946 ± 0.020 (DR). Compared to single image types, the multimodal model based on the ResNet-50 model performs better in the binary classification task in the training and validation sets, with both AUC and accuracy exceeding 90%. In multipath detection, the MMAI system performs well in the NG and CD by combining internal and external test set detection, with AUC, accuracy, and F1-score all exceeding 0.9. Our preliminary study developed an MMAI system using Echo and chest DR images, showing potential for assisting in the detection of CD in VSD patients under 1 year of age prior to surgery. Further validation is needed to confirm clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.